Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

A 56-year-old American man was diagnosed with stage 4 head and neck cancer after noticing a weird, painless boil on his ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck cancer. In a recent study, tobacco use increased the risk of developing ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...

Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

There are a number of things to look out for, but many of them often go ignored, according to leading oncologist Dr Jiri ...

The KEYNOTE-689 study showed pembrolizumab with standard of care significantly improved outcomes for resectable HNSCC, ...

Artificial intelligence (AI) tools such as deep learning-based algorithms can be valuable as previous studies have shown a reduction in contouring time and variation. Furthermore, explainable AI (XAI) ...

A Lampeter cancer nurse and international bowler has been named in the King's Birthday Honours List. Anwen Butten, a Head and ...